Der Internist

, Volume 51, Issue 1, pp 103–106

Rosuvastatin zur Primärprävention vaskulärer Komplikationen

JUPITER-Studie (Justification for the Use of statins in Prevention: an Intervention Trial Evaluation Rosuvastatin)
Klinische Studien
  • 73 Downloads

Rosuvastatin for primary prevention of vascular events

JUPITER trial (Justification for the Use of statins in Prevention: an Intervention Trial Evaluation Rosuvastatin)

Literatur

  1. 1.
    Baigent C, Keech A, Kearney PM et al. (2005) Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366: 1267–1278CrossRefPubMedGoogle Scholar
  2. 2.
    Delahoy PJ, Magliano DJ, Webb K et al. (2009) The relationship between reduction in low-density lipoprotein cholesterol by statins and reduction in risk of cardiovascular outcomes: an updated meta-analysis. Clin Ther 31: 236–244CrossRefPubMedGoogle Scholar
  3. 3.
    Genser B, März W (2006) Low density lipoprotein cholesterol, statins and cardiovascular events: A meta-analysis. Clin Res Cardiol 95: 393–404CrossRefPubMedGoogle Scholar
  4. 4.
    Glynn RJ, Danielson E, Fonseca FA et al. (2009) A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med 360: 1851–1861CrossRefPubMedGoogle Scholar
  5. 5.
    Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360: 7–22CrossRefGoogle Scholar
  6. 6.
    Law MR, Wald NJ, Rudnicka AR (2003) Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease and stroke: systematic review and meta-analysis. BMJ 326: 1423CrossRefPubMedGoogle Scholar
  7. 7.
    Ridker PM, Danielson E, Fonseca FA et al.; JUPITER Study Group (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359: 2195–2207CrossRefPubMedGoogle Scholar
  8. 8.
    Ridker PM, Rifai N, Clearfield M et al. (2001) Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 344: 1959–1965CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  1. 1.Klinik für Innere MedizinKlinikum Links der Weser, Gesundheit Nord gGmbH, BremenBremenDeutschland
  2. 2.synlab Medizinisches Versorgungszentrum Heidelberg GmbHEppelheimDeutschland
  3. 3.Institut für Public Health, Sozialmedizin und EpidemiologieMedizinische Fakultät Mannheim der Universität HeidelbergMannheimDeutschland
  4. 4.Werl-WestönnenDeutschland

Personalised recommendations